DiagnaMed Holdings Corp. has announced a collaboration with EIREX, a hydrogen technology company, to develop and commercialize EIREX's innovative technology for extracting hydrogen from water. This technology aims to overcome the challenges faced by traditional electrolysis methods by significantly reducing production costs. The target cost for the commercial pilot prototype is $0.25 per kilogram initially and $0.10 per kilogram for commercial units, which could potentially disrupt the industry's current cost projections. The partnership also seeks to establish relationships with life sciences companies, hospitals, and medical centers to leverage hydrogen for operational purposes, energy backup, and medical treatments. Molecular hydrogen's proven benefits, such as antioxidant and anti-inflammatory properties, make it a promising solution for managing chronic diseases and improving various health conditions. As the global hydrogen generation market continues to expand, with a projected growth rate of 9.3% from 2024 to 2030, the collaboration between DiagnaMed and EIREX holds significant potential for advancing hydrogen technology for medical and industrial applications.